ABSTRACT
INTRODUCTION
Various cancer types differ significantly in terms of morphology, cell of origin, physiology, and pharmacology, but one thing common to most cancer cells is the requirement for intracellular Ca 2+ signaling to maintain malignant phenotypes: sustaining proliferation, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis [1] [2] [3] [4] . Ca
2+
-signaling pathways are remodeled or deregulated in cancer that result in changes in their physiology and distinguish them from non-malignant cells. Remodeling or deregulation of Ca
-signaling pathways can provide means by which cancer cells can overcome systemic anticancer defense mechanisms [5] [6] [7] . Numerous studies have now established that some cancers are associated with major changes in the expression of specific Ca 2+ channels and pumps and that inhibition of some of these proteins inhibits the oncogenicity of cancer cells [8] [9] [10] . Although the dysregulation of Ca 2+ signaling has been observed in tumor progression, the tumor-specific regulators of [Ca 2+ ] i oscillations are poorly characterized. Depending upon the stimulus, Ca 2+ signals are transmitted in the form of repetitive time-dependent changes in its concentration, known as [Ca 2+ ] i oscillations [11] . [Ca 2+ ] i oscillations are proposed to convey information in their amplitude and frequency, leading to the activation of specific downstream targets in response to sustained stimulation by extracellular signaling molecules [12, 13] . The simplest mechanism proposed to describe www.impactjournals.com/oncotarget [Ca 2+ ] i oscillations involves an increase in cytosolic Ca 2+ (upstroke) due to the release of Ca 2+ from intracellular stores following activation of extracellular Ca 2+ influx; and a subsequent decrease in cytosolic Ca 2+ (downstroke) occurs due to the refilling of the stores with Ca 2+ following inactivation of extracellular Ca 2+ influx [14, 15] . As a cancer biomarker, CD147 is highly expressed in hepatocellular carcinoma (HCC) but weakly expressed in normal liver tissues [16] . CD147 is also significantly expressed in various cancers and appears to have prognostic significance, rendering it a possible cancer-associated biomarker for pathological diagnosis, prognostic evaluation,targeted therapy and radioimmunoimaging of a broad range of cancer types. [17] Prior studies have demonstrated that CD147 plays important roles in the progression of HCC, including migration, proliferation, tumor recurrence and poor prognosis [16, 17] . Our prior study indicated that CD147 activates the FAK-PI3K-calcium (Ca
) signaling pathway by interacting with a3b1 integrin and disrupts the NO/ cGMP-mediated negative regulation of store-operated Ca 2+ entry, thus increasing the intracellular level of Ca 2+ level in HCC cells [18, 19] . In this study, we demonstrated that CD147, functions as a critical regulator of ER-dependent [Ca 2+ ] i oscillations to correlate with the progression in HCC.
RESULTS

CD147 promotes HCC cells invasion, migration and proliferation by regulating [Ca
2+ ] i oscillations
We investigate the expression of CD147 in a range of hepatoma cancer-derived and nonmalignant liver cells. CD147 was highly upregulated in hepatoma cancer-derived cell lines (Supplementary Figure 1A) . To assess the effect of CD147 on [Ca 2+ ] i oscillations, we used lentiviral delivery of shRNA constructs to knock down expression of endogenous CD147 proteins in HepG2 and SMMC-7721 cells (Supplementary Figure 1B- ] i of control cells and CD147 knockdown cells after treatment with ionomycin, which could transport calcium from the ER into the cytosol. In Ca
2+
-free medium, the peak levels of Ca 2+ released by ionomycin were identical in control cells and CD147 knockdown cells ( Figure 2B ). The above results suggest that CD147 increases Ca 2+ release from ER stores but does not alter the ER Ca 2+ content. IP3R is predominant ER Ca 2+ releasing channel. We found that CD147 knockdown reduced Ca 2+ release from ER stores. However, CD147 knockdown did not reduce Ca 2+ release from ER stores following IP3R inhibitor Xestospongin C (XeC) treatment ( Figure 2C ). The result suggests that IP3R is involved in CD147-promoted Ca release. Moreover, we found that the major IP3R isoform expressed in HCC is IP3R1 (Supplementary Figure 2A) and CD147 did not influence IP3R1 expression levels ( Figure 2D ). It is known that IP3R1 can be phosphorylated at tyrosine (Tyr), serine (Ser) and threonine (Thr). We then investigated the effects of CD147 on phosphorylated Tyr, Ser and Thr of IP3R1. The results showed that CD147 knockdown markedly decreased phosphorylated Tyr of IP3R1, however, CD147 knockdown did not change phosphorylated Ser and Thr of IP3R1 (Figure2E). To directly address this issue, we constructed a Tyr353-mutated IP3R1 (IP3R1-Y353F). Immunoprecipitation (IP) showed that, compared with CD147 co-transfection with IP3R1 (WT), CD147 co-transfection with Tyr353-mutated IP3R1 (Y353F) suppressed IP3R1 Tyr353 phosphorylation levels ( Figure 2F ), indicating that CD147 may induce IP3R1 phosphorylation at Tyr353. To further detect whether the CD147-promoted cell oncogenicity was mediated by [Ca 2+ ] i oscillations in HCC cells, we tested the proliferation, invasion and migration in HepG2 cells which were transfected with IP3R1(WT) or IP3R1-Y353F vector. We found that CD147 promoted proliferation, invasion and migration in HepG2 cells transfected with IP3R1(WT) vector. However, CD147 did not apparently promote proliferation, invasion and migration in HepG2 cells transfected with IP3R1-Y353F vector (Supplementary Figure 2B-2D) . The results strengthen the The tyrosine phosphorylation of IP3R1 is dependent on Src activity. We demonstrated that CD147 knockdown markedly decreased the Src phosphorylation in HepG2 cells ( Figure 2G ). Then we found that the Src inhibitor markedly decreased Tyr phosphorylation of IP3R1, and CD147 knockdown did not further reduce Tyr phosphorylation of IP3R1 after Src inhibitor treatment ( Figure 2H ). It is known that FAK activates Src through occupancy of the Src SH2 domain. We further confirmed that CD147 knockdown markedly decreased the FAK phosphorylation levels ( Figure 2I) ] ER ) with the low-affinity fluorescent Ca 2+ indicator mag-fura-2 AM. We found that the refill rate was severely depressed in CD147 knockdown cells ( Figure 3B ). These results indicated that CD147 may accelerate ER Ca 2+ refilling.
To address whether CD147-mediated Ca 2+ refilling occurs through the SERCA pump, thapsigargin (Tg), an irreversible SERCA inhibitor, was used. The addition of Tg completely abolished CD147-mediated Ca 2+ refilling, indicating that CD147-mediated Ca 2+ refilling requires SERCA pump activity ( Figure 3B ). However, we found CD147 did not alter the expression of SERCA in HepG2 cells ( Figure 3C ). It has been well documented that phospholamban (PLB) negatively regulates SERCA activity in the ER by direct association. The phosphorylation of PLB at Ser16 causes its disassociation from SERCA, and the subsequent relief of SERCA inhibition [9] . After initiating ER Ca 2+ refilling, we found that PLB Ser16 phosphorylation levels were markedly decreased in CD147 knockdown cells ( Figure 3D ). Corresponding co-IP tests further demonstrated that CD147 knockdown significantly increased the binding of PLB to SERCA ( Figure 3E ). These results demonstrated that CD147 causes PLB disassociation from SERCA and subsequent relief of SERCA inhibition by promoting the phosphorylation of PLB at Ser16. Activated PP2A and PP1 could associate with PLB and dephosphorylation of PLB at Ser16. The phosphorylation of protein phosphatase1 (PP1) and phosphatase type-2A (PP2A) leads to inhibition of PP1 and PP2A enzyme activity, respectively [11] . The result that CD147 knockdown markedly increased the phosphorylated PP2A but did not influence the phosphorylated PP1 suggested that CD147 may suppress PP2A activity ( Figure 3F ). Moreover, CD147 knockdown did not further reduce phosphorylated PLB levels following PP2A inhibitor treatment ( Figure 3G ). Correspondingly, co-IP tests further demonstrated that CD147 knockdown did not increase the binding of PLB and SERCA following PP2A inhibitor treatment ( Figure  3H ). These results indicate that CD147 may promote PLB phosphorylation and enhance PLB dissociation from SERCA by suppressing PP2A activity.
The phosphorylation of p21-activated kinase 1 (PAK1) at Thr-423 induces a conformational change in PP2A that promotes PP2A dephosphorylation and increases its activity [11] . CD147 knockdown markedly increased the phosphorylation of Thr423 in PAK1 ( Figure  3I ). PAK1 siRNA led to a marked reduction of the PAK1 levels in HepG2 cells (Supplementary Figure 3A & 3B), and CD147 knockdown did not further increase PP2A phosphorylation following PAK1 depletion ( Figure 3J ). The result suggested that CD147 suppressed PP2A activity through inhibiting PAK1 phosphorylation. Ca
-dependent protein kinase phosphatase (CaMKP) associates with and dephosphorylates PAK1, leading to the inactivation of this kinase [21] . The CaMKP inhibitor treatment increased PAK1 phosphorylation in HepG2 cells ( Figure 3K ). Treatment of cells with CaMKP inhibitor blocked the CD147-induced dephosphorylation of PAK1 and CD147-induced phosphorylation of PP2A and PLB ( Figure 3L ). CD147 knockdown did not increase the binding of PLB to SERCA following CaMKP inhibitor treatment ( Figure 3M ). These data indicate that CD147 may inhibit PAK1 phosphorylation by activating CaMKP. Together, CD147 activates CaMKP to inhibit PAK1 phosphorylation and subsequently suppresses PP2A activity. CD147-inactivated PP2A increases phosphorylation of PLB and enhances disassociation of PLB from SERCA, thus promoting SERCA pump activity and rapid ER Ca 2+ refilling. ] ER was measured with magfura-2-AM. Control cells, n = 10; CD147 knockdown cells, n = 14. C. SERCA and D. phosphorylated PLB were tested. E. Endogenous SERCA complexes were isolated and examined for the presence of PLB by coimmunoprecipitation assay. IP with anti-lgG antibody was used as the negative control. F. Phosphorylated PP2A and PP1 were tested. G. Western blot analysis of phosphorylated PLB in cells after PP2A inhibitor treatment. H. Endogenous SERCA complexes were examined for the presence of PLB by coimmunoprecipitation assay after PP2A inhibitor treatment. I. Phosphorylated PAK1 were tested. (Figure 5A ). Furthermore, CD147 knockdown markedly increased phosphorylated PAK1 levels in the presence but not in the absence of high [Ca 2+ ] i ( Figure 5A 
] i conditions ( Figure 5C ). We then observed that CD147 knockdown did not alter the CaMKP expression levels ( Figure 5D ). CaMKP activity tests showed that CaMKP incubated with CD147 was not significantly activated in either the presence or the absence of Ca 2+ ( Figure 5E lane 2, 3) . CaMKII, a Ca 2+ -active multifunctional protein kinase, which was found to phosphorylate and activate CaMKP [22, 23] , was added to the reaction mixture. CD147 increased CaMKP activation in the presence of CaMKII and Ca 2+ ( Figure 5E  lane 4, 5) . The dephosphorylation of PAK1 induced by CD147 in high [Ca 2+ ] i conditions was largely blocked by pretreatment with CaMKII inhibitor KN-93 ( Figure 5F ). In addition, the CD147-CaMKP interaction, which was found to be constitutive under high [Ca ] i oscillations CD147, also named basigin in mice. Mice with conditional null allele for basigin were generated in our lab [24] . To analyze whether CD147-promoted tumor development were mediated by [Ca 2+ ] i oscillations in vivo, we compared the phenotypes of livers with deletion of basigin. Using the Cre-loxP approach, basiginfloxed mice were crossed with Alb-Cre transgenic mice to derive Alb-Cre; Bsg fl/fl mice as described [24] . We designed PCR primers to amplify the deleted allele (using primers P1 : 5'-CTGGAACTCCTAGCAATC-3' and P2 : 5'-AGGTGGGTTTTCTGTAAGGT-3', 614-bp product in length) and undeleted allele (using primers P3 : 5'-CTCTGGGACTCAATGTGTGT-3' and P2: IP3R1 is an intracellular Ca
-release channel predominantly located on the ER and responsible for a controlled release of Ca 2+ in the cytoplasm. Functional experiments confirm that tyrosine phosphorylation of IP3R1 leads to a 5-fold increase in affinity for IP3 and promotes IP3R1 open probability. We demonstrated that during ER Ca 2+ release stage, the higher level of IP3R1 phosphorylation in the presence of CD147, which is mediated by the FAK-Src pathway, would lead to a high In the present study, we discovered that CD147 acts as a critical regulator of ER-dependent [Ca 2+ ] i oscillations to promote oncogenic activities and influence the progression of HCC. The inhibition of CD147 may therefore represent a novel approach to inhibit the dysregulation of Ca 2+ signaling and HCC metastasis and proliferation. In addition to its effects in HCC cells, we have also established that CD147 is highly expressed in other cancers, including breast, lung and bladder cancer gliomas and laryngeal squamous cell, ovarian, renal cell and skin carcinomas [17] . As CD147 is a widely expressed cancer biomarker, its molecular signaling cascade, as well as the mechanism and consequences of its activation in HCC, could also exist in other molecule in developing therapies. In this regard, CD147 may represent a novel anti-cancer target in tumor treatments.
MATERIALS AND METHODS
Cell culture
Human HepG2, SMMC-7721, Huh-7, QZG and HL-7702 cells (Institute of Cell Biology, China) were cultured in RPMI 1640 medium (Gibco, Grand Island, USA) supplemented with 10% FBS, 1% penicillin/streptomycin and 2% L-glutamine at 37°C in a humidified atmosphere of 5% CO 2 . ] i was measured as described previously [26] . Briefly, cells were loaded by incubation in culture medium containing AM derivatives of Mag-Fura2 for 60 minutes at 37°C and then removed the cytoplasmic fraction of the dye. The cells were subsequently treated with BHQ or Tg to deplete the ER Ca 2+ stores, and 2mM Ca 2+ was added to initiate ER Ca
Cytoplasmic [Ca
] i were recorded from Fluo-8/AM or MagFura 2/AM loaded cells, which were excited at 340 nm and 380 nm and imaged with 510 nm filters, and the F340/F380 ratios of the fluorescence intensities were calculated after subtraction of background fluorescence and correction for bleaching. The fluorescence signal was monitored and recorded by an FV300 laser scanning confocal microscope (Olympus, Japan, Tokyo). All experiments were repeated 3 to 6 times. Statistical significance was determined with Student's t-test analysis; p < 0.05 was considered significant. All data are shown as the average ± SEM. www.impactjournals.com/oncotarget
Gene silencing
The sense sequence for CD147 shRNA was 5'-GGTTCTTCGTGAGTTCCTC-3' and negative control shRNA (control shRNA) for CD147 was 5'-GACTTCATAAGGCGCATGC-3' (Ambion, Austin, TX, USA). The PAK1 siRNA sequence was 5'-TTTCTTCTTAGGATCGCCCACACTC-3' and negative control siRNA (control siRNA) for PAK1 was 5'-AGTCGACGTCAGCGAAGGC-3' (Ambion, Austin, TX, USA). The PTP-PEST siRNA sequence was 5'-GGCAATTCCTCAGATATCA-3' and negative control siRNA (control siRNA) for PTP-PEST was 5'-GGCAATTCCCCAGATATCA-3' (Ambion, Austin, TX, USA).
In vitro invasion assays
The assay was performed using chambers with polycarbonate filters (8 μm pore size; Millipore). The upper side of a polycarbonate filter was either coated or not coated with Matrigel to form a continuous thin layer. HCC cells (1×10 5 ) were resuspended in 300 μL of 0.1% serum medium and added to the upper chamber. The lower chamber was filled with 10% FBS medium (200 μL). After 24 h incubation, the cells on the upper chamber of the filter were removed with a cotton swab, and the cells on the underside were stained and counted.
Wound healing assay
HCC cells (2×10 6 ) were plated in six-well plates and cultured to approximately 90% confluence. The cells were scraped with a pipette tip, washed several times in serumfree medium, and then examined under a phase contrast microscope (Olympus, Japan, Tokyo). The cells were refed with 10% FBS medium for 24 h, and images were obtained.
Cell growth tests
HCC cells were cultured in 96-well plate (1×10 4 per well) for 24 h. Each condition was performed in triplicate. After incubation, the cells were harvested and counted at every 24 h. The doubling time (T) was calculated according to the formula T = t×log 2/ (log N t -log N 0 ). N t indicates the number of cells after culture for t hours, N 0 indicates the number of cells at the beginning of the culture, and t indicates the culture time.
Western blot analysis
Cells were lysed in 1% OG buffer (20 mM TrisHCl, pH 8.0, 150 mM NaCl, 1% OG, 1 mM EDTA, 10 µg/ml leupeptin, 2 µg/ml aprotinin and 1 mM PMSF). A BCA Protein Assay Kit (Pierce Biotechnology, Rockford, Illinois) was then used to determine the total protein concentration, and equal amounts of protein were separated by 10% SDS-PAGE and transferred to a polyvinylidene fluoride (PVDF) microporous membrane (Millipore, Billerica, MA). The membrane was blocked with 5% non-fat milk and then incubated for 2 h at room temperature with the designated antibody. The WesternLight chemiluminescent detection system (Applied Biosystems, Foster, CA) was used for immunodetection.
Reverse transcription PCR and data analysis
Total RNA was extracted with TRIzol reagent (Invitrogen, California, USA) and reverse transcribed into cDNA with the ReverTra Ace-a kit (Toyobo, Shanghai, China). The primers and probes used were as follows: CD147 forward primer, 5'-TCGCGCTGCTGGGCACC-3', CD147 reverse primer, 5'-TGGCGCTGTCATTCAAGGA-3'; PTP-PEST forward primer, 5'-GGAGGATGGAGCAAGTGG-3', PTP-PEST reverse primer, 5'-GCAGCGTGTAACAGGGTT-3'; PAK1 forward primer, 5'-GGGAGAAAGTGAAGCGGTAG-3', PAK1 reverse primer, 5'-GGTGTCTGGGCAGTTGAG-3'; IP3R1 forward primer, 5'-CTGCTGGCCATCGCACTT-3', IP3R1 reverse primer 5'-CAGCCGGCAGAAAAACGA-3'; IP3R2 forward primer, 5'-AGCACATTACGGCGAATCCT-3', IP3R2 reverse primer, 5'-CCTGACAGAGGTCCGTTCACA-3'; IP3R3 forward primer, 5'-CGGAGCGCTTCTTCAAGGT-3', IP3R3 reverse primer, 5'-TGACAGCGACCGTGGACTT-3'; and GAPDH, forward primer 5'-AATGTCACCGTTGTCCAGTTGC-3', reverse primer 5'-CACCATCTTAGGAGGAGGAGTAGC-3'. GAPDH mRNA was used as an internal control. The PCR conditions were 1 cycle of 94°C for 5 min; 35 cycles of 94°C for 60 s, 57°C for 30 s, and 72°C for 30 s; and finally 72°C for 5 min. PCR products were electrophoresed on 1% agarose gels.
Plasmid construction
Full-length IP3R1 (WT) was amplified by PCR. The primers (synthesized by the Shanghai Sangon Co.) were designed as follows: forward primer, 5'-GCTCTAGAGCTGACTACAGAGGAGCAGG-3' (XbaI) and reverse primer, 5'-AAGGCCTTAACTCATTAGCCATA-3' (StuI).
The Tyr353-mutated IP3R1 (MT) was PCR-amplified using a QuikChange mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's instructions. The tyrosine codon at amino acid 353 in IP3R1 cDNA was changed to a phenylalanine codon. The mutagenic primers used were as follows (mutations shown in bold): forward primer, 5' -GGACATTCACAAGAGGCTTTCGAGCCATGGTTCT -3' and reverse primer, 5'-AGAACCATGGCTCGAAAGCCTCTTGTGAATGTCC -3'. The products from the full-length IP3R1 (WT) and the Tyr353 mutant IP3R1 (MT) were confirmed by sequencing (Shanghai Sangon, Shanghai, China) and then cloned into pEGFP-N1 (Promega, Madison, WI, USA).
Co-immunoprecipitation
Cells were washed and resuspended in NPBS and then lysed in 1% OG buffer. A BCA Protein Assay Kit (Pierce Biotechnology, Rockford, IL, USA) was then used to determine the total protein density. Lysates (1 mL) were immunoprecipitated by incubation with 2 µg of the designated antibody and 25 µL of protein A-agarose overnight at 4 °C, followed by Western blotting with the designated antibody for 2 h at room temperature. The Western-Light chemiluminescent detection system (Applied Biosystems, Foster City, CA, USA) was used for immunodetection.
Protein phosphatase assay using MUP as a substrate
The protein phosphatase assays were carried out at 30°C for 20 min in a reaction mixture containing 50 mM Tris-HCl (pH 8.0), 20 mM dithiothreitol, 10 mM MnCl 2 , 0.01% Tween 20, 25 μM Methylumbelliferyl Phosphate (MUP), and 1 μg of CaMKP. The reaction was started by the addition of CaMKP and terminated by the addition of EDTA. MUP would be converted to the soluble fluorescent reaction product methylumbelliferone when they are hydrolyzed by CaMKP. The fluorescence of methylumbelliferone present in the reaction mixture was measured by a spectrofluorometer (Molecular devices, CA, USA) with excitation at 360 nm and emission at 440 nm.
Animal model
The conditional null allele for basigin in mice were generated in our lab [24] . Alb-Cre transgenic mice were purchased from Model Animal Research Center of Nanjing University. Basigin-floxed mice were crossed with Alb-Cre transgenic mice to generate Alb-Cre;Bsg fl/ fl mice (backcrossed to C57BL/6 background for more than eight generations). Male mice were injected intraperitoneally with 25 mg/kg body weight of DEN (Sigma-Aldrich, Munich, Germany) at 14 days of age and then 90 mg/kg body weight of DEN at 6 weeks. Mice were killed at 5 months after birth. All of the animal work was approved by the Animal Care and Use Committee of the Fourth Military Medical University and handled in strict accordance with good animal practice as defined by the relevant national animal welfare bodies.
Statistical analysis
Statistical analysis was performed using SPSS 13.0 statistical software. The Student's t-test or one-way ANOVA were used to evaluate the statistical significance in the groups. The data are presented as mean ± SD and p < 0.05 was considered as significant.
